Clinicopathologic characteristics and steroid response of IgM nephropathy in children presenting with idiopathic nephrotic syndrome

APMIS

Volumn 119, Issue 3, 2011, Pages 180-186

  Mubarak, Muhammed ^a   Kazi, Javed I ^a   Shakeel, Shaheera ^a   Lanewala, Ali ^a   Hashmi, Seema ^a   Akhter, Fazal ^a  

^a SINDH INSTITUTE OF UROLOGY AND TRANSPLANTATION   (Pakistan)

Author keywords

Children; IgM nephropathy; Nephrotic syndrome; Pakistan; Renal biopsy

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; CORTICOSTEROID DERIVATIVE; IMMUNOGLOBULIN M;

ARTICLE; CELL PROLIFERATION; CELL STRUCTURE; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; DEMOGRAPHY; FEMALE; FOCAL GLOMERULOSCLEROSIS; HEMATURIA; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOGLOBULIN M NEPHROPATHY; IMMUNOPATHOLOGY; KIDNEY BIOPSY; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; PAKISTAN; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT RESPONSE;

CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN M; KIDNEY; MALE; MICROSCOPY, FLUORESCENCE; NEPHROTIC SYNDROME; PAKISTAN; RETROSPECTIVE STUDIES; STEROIDS;

EID: 79551499271     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2010.02708.x     Document Type: Article

References (26)

1. Cohen AH, Border WA, Glassock RJ. Nephrotic syndrome with glomerular mesangial IgM deposits. Lab Invest 1978;38:610-19.
2. Bhasin HK, Abeulo JG, Nayak R, Esparza AR. Mesangial proliferative glomerulonephritis. Lab Invest 1978;39:21-9.
3. Van de Putte LBA, DeLaRiviere GB, Van Breda Vriesman PJC. Recurrent or persistent hematuria, sign of mesangial immune-complex deposition. N Engl J Med 1974;290:1165-70.
4. Lawler W, Williams G, Tarpey P, Mallick NP. IgM associated primary diffuse mesangial proliferative glomerulonephritis. J Clin Pathol 1980;33:1029-38.
5. Cavalo T, Johnson MP. Immunopathologic study of minimal change glomerular disease with mesangial IgM deposits. Nephron 1981;27:281-4.
6. Mampaso F, Gonzalo A, Teruel J, Losada M, Gallego N, Ortuno J, et al. Mesangial deposits of IgM in patients with the nephrotic syndrome. Clin Nephrol 1981;16:230-4.
7. Helin H, Mustonen J, Pasternack A, Antonen J. IgM associated glomerulonephritis. Nephron 1982;31:11-16.
8. Tejani A, Nicastri AD. Mesangial IgM nephropathy. Nephron 1983;35:1-5.
9. Hsu HC, Chen WY, Lin GJ, Chen L, Kao S-L, Huang C-C, et al. Clinical and immunopathologic study of mesangial IgM nephropathy: report of 41 cases. Histopathology 1984;8:435-46.
10. Border WA. Distinguishing minimal change disease from mesangial disorders. Kidney Int 1988;34:419-24.
11. Chan YH, Wong KM, Choi KS, Chak WL, Cheung CY. Clinical manifestation and progression of IgM mesangial nephropathy: a single center perspective. Hong Kong J Nephrol 2000;2:23-6.
12. Donia AF, Sobh MA, Moustafa FE, Bakr MA, Foda MA. Clinical significance and long term evolution of minimal change histopathologic variants and of IgM nephropathy among Egyptians. J Nephrol 2000;13:275-81.
13. Kopolovic J, Shvil Y, Pomeranz A, Ron N, Rubinger D, Oren R. IgM nephropathy: morphological study related to clinical findings. Am J Nephrol 1987;7:275-80.
14. Saha H, Mustonen J, Pasternack A, Helin H. Clinical follow up of 54 patients with IgM nephropathy. Am J Nephrol 1989;9:124-8.
15. Myllymaki J, Saha H, Mustonen J, Helin H, Pasternack A. IgM nephropathy: clinical picture and long term prognosis. Am J Kidney Dis 2003;41:343-50.
16. Hamed RMA. Clinical significance and long term evolution of mesangial proliferative IgM nephropathy among Jordanian children. Ann Saudi Med 2003;23:323-7.
17. Jungthirapanich J, Singkhwa V, Watana D, Futrakul P, Sensirivatana R, Yenrudi S. Significance of tubulointerstitial fibrosis in paediatric IgM nephropathy. Nephrology 1997;3:509-14.
18. Kishimoto H, Arakawa M. Clinico-pathological characterization of mesangial proliferative glomerulonephritis with predominant deposition of IgM. Clin Exp Nephrol 1999;3:110-15.
19. Sumboonnanonda A, Chongchate N, Suntornpoch V, Pattaragarn A, Supavekin S. Difficult-to-treat nephrotic syndrome: management and outcome. J Med Assoc Thai 2005;88:S142-8.
20. Mubarak M, Lanewala A, Kazi JI, Akhter F, Sher A, Fayyaz A, et al. Histopathological spectrum of childhood nephrotic syndrome in children in Pakistan. Clin Exp Nephrol 2009;13:589-93.
21. Lanewala A, Mubarak M, Akhter F, Aziz S, Bhatti S, Kazi JI. Pattern of pediatric renal disease observed in native renal biopsies in Pakistan. J Nephrol 2009;22:739-46.
22. Cattran DC, Coppo R, Cook T, Feehally J, Roberts ISD, Troyanov S, et al. The Oxford classification of IgA nephropathy: rationale, clinicopathologic correlations, and classification. Kidney Int 2009;76:534-45.
23. Pardo V, Riesgo I, Zilleruelo G, Strauss J. The clinical significance of mesangial IgM deposits and mesangial hypercellularity in minimal change nephrotic syndrome. Am J Kidney Dis 1984;3:264-9.
24. Habib R, Girardin E, Gagnadoux M-F, Hinglais N, Levy M, Broyer M. Immunopathological findings in idiopathic nephrosis: clinical significance of glomerular "immune deposits". Pediatr Nephrol 1988;2:402-8.
25. Ji-Yun Y, Melvin T, Sibley R, Michael AF. No evidence for a specific role of IgM in mesangial proliferation of idiopathic nephrotic syndrome. Kidney Int 1984;25:100-6.
26. Al Eisa A, Carner JE, Lirenman DS, Magil AB. Childhood IgM nephropathy: comparison with minimal change disease. Nephron 1996;72:37-43.